As a key node in the activation of NLRP3, TXNIP promotes the secretion of pro-inflammatory factors by activating the NF-κB pathway through nuclear translocation in endothelial cells, while inhibiting TNFα-NF-κB signaling in tumor cells to exert anti-inflammatory effects [93, 94]. Here, NFKB1 is linked to neoplasm.